Quantcast

Latest Pyrroles Stories

2008-09-25 12:00:15

Anthera Pharmaceuticals has reached an agreement with the FDA on a Phase III protocol for varespladib in acute coronary syndrome under the FDA's special protocol assessment procedure. At the same time, the company has received scientific advice from the European Medicines Agency (EMEA) on Anthera's European development strategy for varespladib. Anthera has said that the guidance from both regulatory agencies regarding varespladib will be incorporated into the company's global registration...

fefb8acf602e735077902f9fef261c951
2008-09-20 07:50:00

Lipitor has been the top-selling drug in the world and has accounted for over $12 billion in annual sales. It has been prescribed to both men and women to lower cholesterol and reduce the risk of heart attack and stroke in patients with common risk factors for heart disease. However, a new study appearing in the Journal of Empirical Legal Studies was unable to find high quality clinical evidence documenting reduced heart attack risk for women in a primary prevention context. Furthermore,...

2008-08-25 09:00:26

Anthera Pharmaceuticals has started the Francis clinical trial designed to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome event. The Francis trial is designed to assess the impact of oral varespladib on known biological markers of cardiovascular risk. It will enroll up to 500 patients that will be treated for a minimum of six months. The study will be conducted at sites in North America and Europe. Francis will provide...

2006-08-03 17:33:11

LONDON (Reuters) - British authorities have found a new batch of counterfeit packs of Pfizer Inc's Lipitor cholesterol pill in the legitimate supply chain, highlighting the risk posed by fake drugs, officials said on Thursday. The Medicines and Healthcare products Regulatory Agency first seized fake Lipitor tablets in July 2005 and said last month that more packs from that batch had appeared. The packs recalled on Thursday had a different lot number. "The testing of the counterfeit...

2006-05-26 11:40:00

NEW YORK (Reuters Health) - Treating diabetics who have signs of heart disease with a high dose of the cholesterol-lowering drug Lipitor (80 mg daily), rather than the normal dose of 10 mg daily, can lower the rate of major cardiovascular events by 25 percent, according to a new report. In the main analysis of data from the study, increasing the dose of Lipitor (also called atorvastatin) was shown to provide significant clinical benefits for patients with heart disease. In a subanalysis, Dr....

2006-03-13 12:06:29

NEW YORK (Reuters) - Pfizer Inc. on Monday said its Lipitor cholesterol medicine improved kidney function in patients with heart disease in a large clinical study. The drugmaker also said improvement in kidney function was significantly greater among patients taking the 80 milligram highest dose of Lipitor, the world's top-selling prescription drug. The data from the 8,000-patient study was presented at the American College of Cardiology annual scientific meeting in Atlanta.

2006-01-19 15:18:33

NEW YORK (Reuters Health) - Treatment with Lipitor (atorvastatin), one of the popular cholesterol-lowering "statin" drugs, can help the heart pump better in patients with heart failure, according to a new report. By contrast, findings from a much smaller study showed that aside from lowering cholesterol levels, Lipitor did not benefit patients with heart failure. Both reports are published in the Journal of the American College of Cardiology. "Although the reasons for these...

2006-01-19 15:15:00

NEW YORK -- Treatment with Lipitor (atorvastatin), one of the popular cholesterol-lowering "statin" drugs, can help the heart pump better in patients with heart failure, according to a new report. By contrast, findings from a much smaller study showed that aside from lowering cholesterol levels, Lipitor did not benefit patients with heart failure. Both reports are published in the Journal of the American College of Cardiology. "Although the reasons for these discrepant findings are not known,...

2005-09-27 09:02:11

CHICAGO (Reuters) - Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of stroke and heart attack in diabetic patients. Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of heart disease but with other risk factors for the condition. Pfizer said Lipitor also received approval to reduce the risk of stroke in people without evidence of heart disease but with multiple risk...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related